Abstract: An antimicrobial mixture comprising or consisting of: one or more compounds of the formula (I) their salts or solvates, wherein R1 and R2 in each case independently of one another are chosen from the group consisting of: H, OH, F, Cl, Br and I, and wherein X in each case denotes: (CH2)m where m=1, 2 or 3 or OCH2n where n=1, 2 or 3 or O—CH2—CH(R3) where R3=CH3 or CH2OH or (CH2—OpCH2 where p=1 or 2, wherein in the compound(s) of the formula I a primary alcohol function CH2OH is optionally replaced by a radical which is chosen from the group consisting of CH2OR4, COOH and COOR4 and/or a secondary alcohol function CHOH is optionally replaced by the radical CHOR4, wherein each R4 denotes an aliphatic or aromatic radical, independently of the meaning of further radicals, and one, two or more compounds chosen from the group consisting of the tropolones of the formula (II) wherein the substituents R5, R6, R7, R8, R9 independently of one another have the following meaning: H; linear or branched

Abstract: Compositions comprising dihydroavenanthramide D and climbazole; and, cosmetics or pharmaceutical end products comprising the compositions, useful for treating skin and/or hair.

Abstract: The invention relates to a mixture comprising or consisting of: (a) one or more compounds of Formula 1: where the symbols in the compound or each compound of Formula 1 are defined as follows: m=0, 1, 2 or 3, p=0, 1 or 2, n=0, 1 or 2, where, when n=1 or 2, R1 and R2 in pairs are each H or together are another chemical bond, where, when m=1, 2 or 3, each X independently of the others is OH, O-alkyl or O-acyl, and where, when p=1 or 2, each Y independently of the others is OH, O-alkyl or O-acyl, and R3=H or alkyl, R3=H also representing the corresponding cosmetically or pharmaceutically acceptable salts and solvates; and (b) one or more antidandruff agents.

Abstract: Antimicrobial active compositions and substances comprising at least one, preferably two, unbranched (straight-chain) 1,2-alkanediols and preferably a further preservative and also to products containing such mixtures in an antimicrobially effective quantity. One example of an antimicrobial mixture comprises: (a) 1,2-hexanediol and 1,2-octanediol and also optionally 1,2-pentanediol and/or 1,2-decanediol and (b) one, two or more substances selected from the group consisting of potassium sorbate, parabens and iodopropynyl butylcarbamate (IPBC).

Abstract: Disclosed is the use of ?-(1,3)-?-(1,4)-glucan (a) as carrier for carrying a chemical substance through the stratum corneum into deeper layers of the skin and/or (b) for improving the penetration abilities of the chemical substance through the stratum corneum into deeper layers of the skin.

Abstract: An antimicrobial mixture comprising or consisting of: one or more compounds of the formula (I) their salts or solvates, wherein R1 and R2 in each case independently of one another are chosen from the group consisting of: H, OH, F, Cl, Br and I, and wherein X in each case denotes: (CH2)m where m=1, 2 or 3 or OCH2n where n=1, 2 or 3 or O—CH2—CH(R3) where R3?CH3 or CH2OH or (CH2—OpCH2 where p=1 or 2, wherein in the compound(s) of the formula I a primary alcohol function CH2OH is optionally replaced by a radical which is chosen from the group consisting of CH2OR4, COOH and COOR4 and/or a secondary alcohol function CHOH is optionally replaced by the radical CHOR4, wherein each R4 denotes an aliphatic or aromatic radical, independently of the meaning of further radicals, and one, two or more compounds chosen from the group consisting of the tropolones of the formula (II) wherein the substituents R5, R6, R7, R8, R9 independently of one another have the following meaning: H; linear or branched

Abstract: A pharmaceutical composition containing at least one systemically and/or locally effective, topically applicable active substance, preferably selected from the group consisting of local anaesthetics, anti-allergic agents, dermatics, active substances for influenzal infections and colds, active substance for the treatment of neuropathies, chemotherapeutics, quinine, thalidomide, analgesics, non-steroid antirheumatics, opiate receptor agonists, opiate receptor antagonists, substances inhibiting the blood coagulation, substances inhibiting platelet aggregation, corticoids, histamine antagonists, anti-diabetics, regulatory peptides and the inhibitors thereof, prostaglandins and/or the esters thereof and/or antivirally effective substances is described.

Abstract: The present invention is related to new parenteral preparations of 2-phenyl-1.2-benzisoselenazol-3(2H)-one (Ebselen) comprising additionally one or several phospholipids and, possibly, one or several auxiliary agents. The invention is further related to a process for producing such solutions and their use in the preparation of drug preparations ob Ebselen.